New cancer clinical trial: Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations

Published on: June 27, 2018 at 12:00PM
Conditions:   Metastatic Castration Resistant Prostate Cancer;   Metastatic Cancer
Interventions:   Drug: Nivolumab;   Drug: Ipilimumab
Sponsors:   University of Michigan Cancer Center;   Memorial Sloan Kettering Cancer Center;   University of California, San Francisco
Not yet recruiting
https://ift.tt/2N91XIj